Influence of treatment with vitamin E on the progression of diabetic nephropathy;Vplyv liečby vitamínom E na progresiu diabetickej nefropatie

Vnitrni Lekarstvi

Volumn 49, Issue 7, 2003, Pages 529-534

  Hirnerová, Eva ^a   Krahulec, B ^a   Strbova L ^a   Stecova A ^b   Dekret J ^a   Hajovska A ^c  

^a II Interná Klinika LF UK UN   (Slovakia)

^b FN   (Slovakia)

^c Nestatna Diabetologicka Ambulancia   (Slovakia)

Author keywords

Diabetic nephropathy; Oxidative stress; Thromboxan A2; Vitamin E

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ALBUMIN; ALPHA TOCOPHEROL; MALONALDEHYDE; PROSTACYCLIN; THROMBOXANE A2; THROMBOXANE B2; ANTIOXIDANT;

ADULT; ALBUMIN BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; HUMAN; OXIDATIVE STRESS; PATHOGENESIS; RADIOIMMUNOASSAY; ALBUMINURIA; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ALBUMINURIA; ANTIOXIDANTS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; MIDDLE AGED; OXIDATIVE STRESS; VITAMIN E;

EID: 0042236465     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Borch-Johnsen, K., Nissen, H., Salling, N. et al.: The natural history of insulin-dependent diabetes in Denmark: 2. Long-term survival-who and why. Diabet. Med., 4, 1987: 211-216
2. Bruggeman, L. A., Pellicoro, J. A., Horigan, E. A. et al.: Thromboxane and prostacyclin differentially regulate extracellular matrix gene expression. Kidney Int., 43, 1993: 1219-1225
3. Bursell, S. E., Clermont, A. C., Aiello, L. P. et al.: High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearence in patients with type 1 diabetes. Diabetes Care, 22, 1999: 1245-1251
4. Coffman, T. M., Carr, D. R., Yarger, W. E. et al.: Evidence, that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. Transplantation, 43, 1987: 282-285
5. Collier, A., Rumley, A., Rumley, A. G. et al.: Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes, 41, 1992: 909-913
6. Collier, A., Wilson, R., Bradley, H. et al.: Free radical activity in type II diabetes. Diabet. Med., 7, 1990: 27-30
7. Craven, P. A., Studer, R. K., Negrete, H. et al.: Protein kinase C in diabetic nephropathy. J. Diabet. Complicat., 9, 1995: 241-245
8. DeRubertis, F. R., Craven, P. A.: Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. Am. J. Kidney Dis., 22, 1993: 727-735
9. Diplock, A. T., Xu, G. L., Yeow, C. L. et al.: Relationship of tocopherol structure to biological activity, tissue uptake, and prostaglandin biosynthesis. Ann. N. Acad. Sci., 570, 1989: 72-84
10. Giustina, A., Perini, P., Desenzani, P. et al.: Longterm treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients. Diabetes, 47, 1998; 423-430
11. Hishinuma, T., Tsukamoto, H., Suzuki, K. et al.: Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids, 65 (4), 2001: 191-196
12. Jain, S. K., Krueger, K. S., McVie, R. et al.: Relationship of blood thromboxane-B2 (TXB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TXB2 and lipid peroxide levels in type 1 diabetic patients. Diabetes Care, 21, 1998: 1511-1516
13. Karpen, C. W., Pritchard, K. A., Arnold, J. H. et al.: Restoration of the prostacyclin/thromboxane A2 balance in the diabetic rat: influence of vitamin E. Diabetes, 31, 1982: 947-951
14. Katayama, S., Inaba, M., Maruno, Y. et al.: Increased thromboxane B2 excretion in diabetes mellitus. J. Lab. Clin. Med., 109, 1987: 711-717
15. Koya, D., Lee, I. K., Ishii, H. et al.: Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol., 8, 1997: 426-435
16. Kunisaki, M., Bursell, S. E., Clermont, A. C. et al.: Vitamin E treatment prevents diabetes-induced abnormality in retinal blood flow via the diacylglycerol-protein kinase C pathway. Am. J. Physiol., 269, 1995: 239-246
17. Kunisaki, M., Umeda, F., Inoguchi, T. et al.: Effects of vitamin E administration on platel function in diabetes mellitus. Diabet. Res., 14, 1990: 37-42
18. Mené, P., Abboud, H. E., Dunn, M. J.: Regulation of human mesangial cell growth in culture by thromboxane A2 and prostacyclin. Kidney Int., 38, 1990: 232-239
19. Mené, P., Pugliese, F., D'Agostino, A. et al.: Thromboxane A2, prostaglandins, and mesangial cell proliferation. Kidney Int., 41, 1992: 554-556
20. Mooradian, A. D.: The antioxidative potential of cerebral microvessels in experimental diabetes mellitus. Brain Res., 671, 1995: 164-169
21. Neilson, E. G.: Tubulointersticial injury and its role in progressive renal damage: Summary and concluding remarks. Kidney Int. 45, 1994; Suppl. 45: 116-117
22. Neri, S., Bruno, C. M., Raciti, C. et al.: Alteration of oxide reductive and haemostatic factors in type 2 diabetics. J. Intern. Med., 236, 1994: 495-500
23. Olson, J. J., Hostetter, T. H., Rennke, H. G. et al.: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int., 22, 1982: 112-116
24. Pont'uch, P., Mikulecký, M., Vozár, J.: Vzt'ah proteinúrie a metabolického vyrovnania u diabetikov I. typu. Bratisl. lek. listy, 84, 1985, 5: 72-78
25. Purkerson, M. L., Joist, J. H., Yates, Y. et al.: Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc. N. Acad. Sci., 82, 1985: 193-197
26. Remuzzi, G., Fitzgerald, A., Patrono, C.: Thromboxane synthesis and action within the kidney. Kidney Int., 41, 1992: 1483-1493
27. Salvati, P., Ferti, C., Ferrario, R. G. et al.: Role of enhanced glomerular synthesis of thromboxane A2 in progressive kidney disease. Kidney Int., 38, 1990: 447-458
28. Schlondorff, D., Ardaillou, R.: Prostaglandins and other arachidonic acid metabolites in the kidney. Kidney Int., 29, 1986: 108-119
29. Skrha, J., Hilgertova, J.: Relationship of serum N-acetyl-beta-glucosaminidase activity to oxidative stress in diabetes mellitus. Clin. Chim. Acta, 282 (1-2), 1999: 167-174
30. Szekacs, B., Vajo, Z., Juhasz, I. et al.: Glomerular prostanoid production is modified by plasma samples of hypertensive and diabetic patients. Acta Physiol. Hung., 85, 1997-1998: 17-28
31. Tesfamariam, B.: Free radicals in diabetic endothelial cell dysfunction. Free Rad. Biol. Med., 16, 1994: 383-391
32. Tkáč, I., Moščovič, F., Molčányiová, A.: Proteinuria is a risk factor for proximal type of peripheral vascular disease in type 2 diabetic patients. Vasa 20, 1991: 22-25
33. Umeda, F., Kuroki, T., Nawata, H: Prostaglandins and diabetic nephropathy. J. Diabet. Complicat., 9, 1995: 334-336
34. Uriu, K., Kaizu, K., Hashimoto, O. et al.: Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic rats. Kidney Int., 45, 1994: 794-802
35. Zhao, B., Zhang, Y., Liu, B. et al.: Endothelial cell injured by oxidized low density lipoprotein. Am. J. Haematol., 49, 1995: 250-252
36. Zoja, C., Perico, N., Bergaamelli, A. et al.: Ticlopidine prevents renal disease progression in rats with reduced renal mass. Kidney Int., 37, 1990: 934-942